We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Captura Biopharma -- Captura announced that it has signed an agreement with GEM Global Yield LLC SCS ("GEM"), the Luxembourg-based private alternative investment group providing Captura with a Share Subscription Facility of up to $50 Million.